Revolving door redux: The DEA's recently departed No. 2 returns to a Big Pharma consulting firm

Washington's revolving door kept spinning this week as the DEA's recently departed second-in-command returned for a new stint with the high-powered consulting firm where he previously advised Purdue Pharma and a drug distributor.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...